Lecanemab: new hope for Alzheimer’s comes at a $56,000 price
The U.S. Food and Drug Administration today approved Leqembi (lecanemab-irmb) under the accelerated approval process for the treatment of Alzheimer’s disease. This new scientific advance in teh fight against...